Skip to main content
. Author manuscript; available in PMC: 2012 Feb 14.
Published in final edited form as: Br J Haematol. 2009 May 12;146(2):158–163. doi: 10.1111/j.1365-2141.2009.07727.x

Table II.

Univariate and multivariate analysis of survival following HL-related HDT-ASCT failure

Variable Hazard ratio p† p‡
Response to first line therapy
 (refractory vs relapsed)
0.57 0.04 0.007
Risk factors prior to salvage
therapy
 (3 vs 0)
1.97 0.23
Response to ICE
 (CR vs PR, MR)
1.27 0.52
Conditioning regimen
 (TLI vs no TLI)
0.92 0.78
Time to HDT-ASCT failure
   After 6 months 0.49 0.01 0.06
   After 12 months 0.48 0.06
Regimens following HDT-
ASCT failure
  Gemcitabine-based 1.31 0.34
  MOPP 0.98 0.96
  Radiation 0.67 0.27
  Second transplant 2.26 0.009 0.004

Univariate analysis

Multivariate analysis